Kathleen E. Harris

Best Publications

• Clinical and Immunologic Criteria for the Diagnosis of Allergic Bronchopulmonary Aspergillosis

  Michael Rosenberg;Roy Patterson;Richard Mintzer;Barry J. Cooper

  1041
  Citations

• Review of Alleged Reaction to Monosodium Glutamate and Outcome of a Multicenter Double-Blind Placebo-Controlled Study

  Raif S. Geha;Alexa Beiser;Clement Ren;Roy Patterson

  326
  Citations

• Prevalence and characterization of asthma in hospitalized and nonhospitalized patients with COVID-19.

  Krishan D. Chhiba;Gayatri B. Patel;Thanh Huyen T. Vu;Michael M. Chen

  300
  Citations

• Cytokines in Chronic Rhinosinusitis. Role in Eosinophilia and Aspirin-exacerbated Respiratory Disease

  Whitney W. Stevens;Christopher J. Ocampo;Sergejs Berdnikovs;Masafumi Sakashita

  293
  Citations

• Specific serum antibodies against isocyanates: association with occupational asthma.

  André Cartier;Leslie Grammer;Jean Luc Malo;Françoise Lagier

  268
  Citations

• Thymic stromal lymphopoietin activity is increased in nasal polyps of patients with chronic rhinosinusitis

  Deepti R. Nagarkar;Julie A. Poposki;Bruce K. Tan;Michael R. Comeau

  261
  Citations

• Evidence of a role for B cell-activating factor of the TNF family in the pathogenesis of chronic rhinosinusitis with nasal polyps.

  Atsushi Kato;Anju Peters;Lydia Suh;Roderick Carter

  214
  Citations

• Evidence for intranasal antinuclear autoantibodies in patients with chronic rhinosinusitis with nasal polyps

  Bruce K. Tan;Quan Zhen Li;Lydia Suh;Atsushi Kato

  195
  Citations

• Heterogeneous inflammatory patterns in chronic rhinosinusitis without nasal polyps in Chicago, Illinois.

  Bruce K. Tan;Aiko I. Klingler;Julie A. Poposki;Whitney W. Stevens

  187
  Citations

• Evidence for altered activity of the IL-6 pathway in chronic rhinosinusitis with nasal polyps

  Anju T. Peters;Atsushi Kato;Ning Zhang;David B. Conley

  185
  Citations

• Heparin immune thrombocytopenia: evidence for a heparin-platelet complex as the antigenic determinant.

  Green D;Harris K;Reynolds N;Roberts M

  172
  Citations

• Oncostatin M promotes mucosal epithelial barrier dysfunction, and its expression is increased in patients with eosinophilic mucosal disease

  Kathryn L. Pothoven;James E. Norton;Kathryn E. Hulse;Lydia A. Suh

  148
  Citations

• Epithelium, inflammation, and immunity in the upper airways of humans: studies in chronic rhinosinusitis.

  Robert P. Schleimer;Atsushi Kato;Anju Peters;David Conley

  139
  Citations

• Neutrophils are a major source of the epithelial barrier disrupting cytokine oncostatin M in patients with mucosal airways disease.

  Kathryn L. Pothoven;James E. Norton;Lydia A. Suh;Roderick G. Carter

  135
  Citations

• Chronic rhinosinusitis with nasal polyps is characterized by B-cell inflammation and EBV-induced protein 2 expression.

  Kathryn E. Hulse;James E. Norton;Lydia Suh;Qiu Zhong

  134
  Citations

• Evidence for diminished levels of epithelial psoriasin and calprotectin in chronic rhinosinusitis

  David D. Tieu;Anju T. Peters;Roderick T. Carter;Lydia Suh

  133
  Citations

• Reduced expression of antimicrobial PLUNC proteins in nasal polyp tissues of patients with chronic rhinosinusitis

  Sudarshan Seshadri;David C. Lin;Mariel Rosati;Roderick G. Carter

  129
  Citations

• Glucocorticoids Enhance or Spare Innate Immunity: Effects in Airway Epithelium Are Mediated by CCAAT/Enhancer Binding Proteins

  Ning Zhang;Quynh Ai Truong-Tran;Brian Tancowny;Kathleen E. Harris

  129
  Citations

• Increased expression of the chemokine CCL23 in eosinophilic chronic rhinosinusitis with nasal polyps.

  Julie A. Poposki;Ashraf Uzzaman;Deepti R. Nagarkar;Regina T. Chustz

  128
  Citations

• Evaluation of the presence of B-cell attractant chemokines in chronic rhinosinusitis.

  Monica Patadia;Julian Dixon;David Conley;Rakesh Chandra

  121
  Citations